Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use

Summary

The purpose of the study is to learn if one year of treatment with parathyroid hormone (PTH), either alone or with risedronate, will increase the thickness of the bones in the hip and spine in subjects with osteoporosis from chronic low dose steroid use. During the second year, the study will also look at whether taking risedronate will preserve the bone thickness created by one year of rhPTH 1-34 treatment.

Timeline

Start

2005-09

Primary completion

2009-03

Completion

2009-05

Drugs

Indications